Trial intelligence / Profile preview

Inhaled Budesonide in Bronchial Dysplasia

NCT00005880Phase 2Completed

Sponsor
BC Cancer
Start
Jul 2000
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of budesonide in lung cancer, sponsored by BC Cancer. Started Jul 2000; status: completed.

02

Drugs

budesonide
03

Conditions

lung cancer

Beyond the preview

Go deeper on NCT00005880.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00005880.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call